STOCK TITAN

MindMed to Present at the Jefferies London Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

On November 12, 2021, Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) announced that its CEO, Robert Barrow, will speak at the Jefferies 2021 London Healthcare Conference from November 16-19. The management team will be available for both in-person and virtual one-on-one meetings. A webcast of Barrow's presentation will be available on-demand starting November 17 at 9:20 AM GMT. MindMed is focused on developing psychedelic-inspired therapies for mental illness.

Positive
  • None.
Negative
  • None.

NEW YORK, Nov. 12, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that its CEO, Robert Barrow, will be speaking at Jefferies 2021 London Healthcare Conference, taking place on November 16-19. Management will be available during the conference for in-person and virtual one-on-one meetings.

A video webcast of the presentation will be available for viewing on-demand beginning on Wednesday, November 17 at 9:20 AM GMT for those registered for the event. The webcast will also be accessible in the "Investors" section of MindMed's website. MindMed will maintain an archived replay of the webcast on its website for 30 days after the conference.

About MindMed

MindMed is a clinical-stage psychedelic medicine biotech company that seeks to discover, develop and deploy psychedelic-inspired medicines and therapies to address addiction and mental illness. The Company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including psilocybin, LSD, MDMA, DMT and an ibogaine derivative, 18-MC. The MindMed executive team brings extensive biopharmaceutical experience to MindMed's approach to developing the next generation of psychedelic-inspired medicines and therapies.

MindMed trades on the NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED. MindMed is also traded in Germany under the symbol MMQ.

Media Contact: mindmed@150bond.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/mindmed-to-present-at-the-jefferies-london-healthcare-conference-301422852.html

SOURCE Mind Medicine (MindMed) Inc.

FAQ

What is Mind Medicine (MindMed) doing at the Jefferies 2021 London Healthcare Conference?

MindMed will have its CEO Robert Barrow speaking at the conference and management will be available for one-on-one meetings.

When will Robert Barrow's presentation be available for viewing?

The presentation will be available on-demand starting November 17, 2021, at 9:20 AM GMT.

Where can I watch the MindMed presentation from the Jefferies conference?

The webcast can be accessed at the Jefferies conference website or in the 'Investors' section of MindMed's website.

What are MindMed's areas of focus?

MindMed is focused on developing psychedelic-inspired therapies to address addiction and mental illness.

What stock symbol does MindMed trade under?

MindMed trades on NASDAQ under the symbol MNMD.

Mind Medicine (MindMed) Inc. Common Shares

NASDAQ:MNMD

MNMD Rankings

MNMD Latest News

MNMD Stock Data

636.89M
73.33M
1.14%
57.45%
12.54%
Biotechnology
Medicinal Chemicals & Botanical Products
Link
United States of America
NEW YORK